DNA Methylation of PXDN Is Associated with Early-Life Adversity in Adult Mental Disorders
Biomolecules · 2024
DOI: 10.3390/biom14080976 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Susanne Edelmann und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Psychotherapy, University Hospital of Tuebingen, Eberhard Karls University of Tuebingen, 72076 Tuebingen, Germany. Hauptthemen laut MEDLINE: DNA Methylation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Brain and Behavior Research Foundation, Ministry of Science, Research and Arts, Baden-Württemberg.
Abstract (Originalsprache)
Early-life adversity (ELA) is characterized by exposure to traumatic events during early periods of life, particularly involving emotional, sexual and/or physical adversities during childhood. Mental disorders are strongly influenced by environmental and lifestyle-related risk factors including ELA. However, the molecular link between ELA and the risk of an adult mental disorder is still not fully understood. Evidence is emerging that long-lasting changes in the epigenetic processes regulating gene expression, such as DNA methylation, play an important role in the biological mechanisms linking ELA and mental disorders. Based on a recent study, we analyzed the DNA methylation of a specific CpG site within the gene PXDN—cg10888111—in blood in the context of ELA across a set of psychiatric disorders, namely Borderline Personality Disorder (BPD), Major Depressive Disorder (MDD) and Social Anxiety Disorder (SAD), and its potential contribution to their pathogenesis. We found significant hypermethylation in mentally ill patients with high levels of ELA compared to patients with low levels of ELA, whereas cg10888111 methylation in healthy control individuals was not affected by ELA. Further investigations revealed that this effect was driven by the MDD cohort. Providing a direct comparison of cg10888111 DNA methylation in blood in the context of ELA across three mental disorders, our results indicate the role of PXDN regulation in the response to ELA in the pathogenesis of mental disorders, especially MDD. Further studies will be needed to validate these results and decipher the corresponding biological network that is involved in the transmission of ELA to an adult mental disorder in general.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry and Psychotherapy, University Hospital of Tuebingen, Eberhard Karls University of Tuebingen, 72076 Tuebingen, Germany.
- German Center for Mental Health (DZPG), Partner Site Tuebingen, 72076 Tuebingen, Germany.
- Max Planck Fellow Group Precision Psychiatry, Max Planck Institute of Psychiatry, 80804 Munich, Germany.
- Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, 80336 Munich, Germany.
Förderung
- Deutsche Forschungsgemeinschaft
- Brain and Behavior Research Foundation
- Ministry of Science, Research and Arts, Baden-Württemberg
- German Research Foundation
- German Center for Mental Health
- DFG
Zitieren
APA
Edelmann, S., Balaji, J., Pasche, S., Wiegand, A., & Nieratschker, V. (2024). DNA Methylation of PXDN Is Associated with Early-Life Adversity in Adult Mental Disorders. Biomolecules. https://doi.org/10.3390/biom14080976
Vancouver
Edelmann S, Balaji J, Pasche S, Wiegand A, Nieratschker V. DNA Methylation of PXDN Is Associated with Early-Life Adversity in Adult Mental Disorders. Biomolecules. 2024. doi:10.3390/biom14080976
BibTeX
@article{Edelmann2024,
author = {Edelmann, Susanne and Balaji, Jeysri and Pasche, Sarah and Wiegand, Ariane and Nieratschker, Vanessa},
title = {DNA Methylation of PXDN Is Associated with Early-Life Adversity in Adult Mental Disorders},
journal = {Biomolecules},
year = {2024},
doi = {10.3390/biom14080976}
}
EUVIMED